Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 8, 2026, 3:59 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 961–984 of 3,978 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Pathophysiology Clear all

Conditions: Ventilator Induced Diaphragm Dysfunction
Interventions: TransAeris; Device
Lead sponsor: Synapse Biomedical; Industry
Eligibility: 22 Years and older
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Lupus Erythematosus, Systemic
Interventions: Project EVO Multi- Treatment; Device
Lead sponsor: National Jewish Health; Other
Eligibility: 18 Years to 65 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Denver, Colorado

Conditions: Covid19, Muscle Atrophy, Muscle Weakness
Interventions: Electrical Stimulation, Electrical Stimulation - Sham; Device
Lead sponsor: Baylor College of Medicine; Other
Eligibility: 18 Years to 100 Years
Enrollment: 19 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Cardiac Dysfunction
Interventions: Echocardiogram; Diagnostic Test
Lead sponsor: Shriners Hospitals for Children; Other
Eligibility: Up to 18 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Olfactory Disorder, Anosmia, Viral Infection, Theophylline Causing Adverse Effects in Therapeutic Use, Smell Disorder
Interventions: Theophylline, Saline Nasal; Drug
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years to 70 Years
Enrollment: 27 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Female Sexual Dysfunction, Overactive Bladder
Interventions: Anticholinergic, PTNS; Drug · Procedure
Lead sponsor: Medstar Health Research Institute; Other
Eligibility: 18 Years and older · Female only
Enrollment: 175 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 5
States / cities: Washington D.C., District of Columbia • Indianapolis, Indiana • Louisville, Kentucky + 2 more

Conditions: Sleep Apnea, Obstructive, Hypoxia, Hypercapnia, Sleep Disorders, Obesity, Hypertension, Coronary Artery Vasospasm, Right Ventricular Overload, Left Ventricular Function Systolic Dysfunction, Ventricular Hypertrophy
Interventions: Clinically prescribed CPAP therapy; Other
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 21 Years to 50 Years
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2014
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Parkinson's Disease, Mild Cognitive Impairment
Interventions: Combined STN+NBM DBS; Device
Lead sponsor: Helen M. Bronte-Stewart; Other
Eligibility: 21 Years to 80 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Stanford, California

Conditions: Heart; Dysfunction Postoperative, Cardiac Surgery, Genetic Predisposition to Disease, Atrial Fibrillation, Myocardial Infarction, Heart Failure
Interventions: Not listed
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 20 Years to 90 Years
Enrollment: 4,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2000 – 2030
U.S. locations: 3
States / cities: Boston, Massachusetts • Dallas, Texas • Houston, Texas

Conditions: Fragile X Syndrome, FXS, Fra(X) Syndrome
Interventions: BPN14770, Placebo; Drug
Lead sponsor: Tetra Discovery Partners; Industry
Eligibility: 18 Years to 45 Years · Male only
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Aging, Aging Problems, Memory Loss, Memory Impairment, Memory Disorders in Old Age, Memory Disorder, Spatial, Memory Disorders, Mild Cognitive Impairment, Cognitive Decline, Cognitive Change, Cognition Disorders in Old Age
Interventions: Physical Activity, Cognitive Activity (VR), Physical and Cognitive Activity; Behavioral
Lead sponsor: University of California, San Diego; Other
Eligibility: 50 Years to 85 Years
Enrollment: 150 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2029
U.S. locations: 1
States / cities: San Diego, California

Conditions: Anemia, Sickle Cell
Interventions: NP Battery, MRI; Behavioral · Procedure
Lead sponsor: UCSF Benioff Children's Hospital Oakland; Other
Eligibility: 21 Years to 55 Years
Enrollment: 212 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2004 – 2008
U.S. locations: 12
States / cities: Los Angeles, California • Oakland, California • Hollywood, Florida + 8 more

Conditions: Colorectal Cancer (Diagnosis), Anal Cancer, Sexual Dysfunction Female
Interventions: Mind-Body Group Intervention, Enhanced Usual Care Control (EUCC); Behavioral
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older · Female only
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Cannabinoid Hyperemesis Syndrome
Interventions: Haloperidol; Drug
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Takotsubo Syndrome
Interventions: Tako Breath; Device
Lead sponsor: NYU Langone Health; Other
Eligibility: 21 Years and older
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2027
U.S. locations: 1
States / cities: New York, New York

Conditions: Tricuspid Regurgitation, Right Ventricular Dysfunction, Left Ventricular Dysfunction
Interventions: Echo; Other
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years to 90 Years
Enrollment: 119 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2016
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Coronary Artery Disease, Left Ventricular Dysfunction, Sudden Cardiac Death
Interventions: Defibrillator, Control; Device · Other
Lead sponsor: Abbott Medical Devices; Industry
Eligibility: 18 Years and older
Enrollment: 81 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2011
U.S. locations: 56
States / cities: Anchorage, Alaska • Tucson, Arizona • Glendale, California + 42 more

Conditions: Ileus, Gastrointestinal Dysfunction
Interventions: Alvimopan; Drug
Lead sponsor: Scott Steele; Other
Eligibility: 18 Years and older
Enrollment: 65 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2024
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Alzheimer Disease, Mild Dementia, Mild Cognitive Impairment, Dementia, Dementia, Vascular, Dementia Alzheimers, Dementia, Mild, Dementia, Mixed, Dementia of Alzheimer Type
Interventions: Virtual Kitchen Training; Behavioral
Lead sponsor: Temple University; Other
Eligibility: 65 Years and older
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Pulmonary Arterial Hypertension, Renal Dysfunction
Interventions: UT-15C SR (treprostinil diethanolamine); Drug
Lead sponsor: United Therapeutics; Industry
Eligibility: 18 Years to 79 Years
Enrollment: 16 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010
U.S. locations: 1
States / cities: Orlando, Florida

Conditions: Psychosis
Interventions: Active TMS, Placebo TMS; Device
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years to 35 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Charlestown, Massachusetts

Conditions: Mild Cognitive Impairment
Interventions: Meal-Replacement Therapy, Dietary Counseling; Dietary Supplement · Behavioral
Lead sponsor: Iowa State University; Other
Eligibility: 70 Years to 85 Years
Enrollment: 96 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 2
States / cities: Ames, Iowa • Iowa City, Iowa

Conditions: Post Operative Cognitive Dysfunction
Interventions: Elective Orthopedic Surgery; Procedure
Lead sponsor: HealthPartners Institute; Other
Eligibility: 50 Years to 90 Years
Enrollment: 47 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: Saint Paul, Minnesota

Conditions: Hypertension, Diabetes
Interventions: Salsalate, Carvedilol, Placebo, Intralipid 20%; Drug
Lead sponsor: Emory University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 36 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2011
U.S. locations: 1
States / cities: Atlanta, Georgia

Search by objective public record fields.

Randomized Study of TransAeris® System in Cardiac Surgery Patients at Risk of Prolonged Mechanical Ventilation

Interactive Digital Technology to Assess and Improve Cognitive Dysfunction in Patients With Systemic Lupus Erythematosus

Electrical Stimulation for Critically Ill Covid-19 Patients

Cardiac Arrhythmias and Dysfunction in the Pediatric Burn Patient

Smell Changes & Efficacy of Nasal Theophylline

Sexual Function Trial of Overactive Bladder: Medication Versus PTNS

"Reversibility of Cardiovascular Injury With CPAP Use: Mechanisms Involved"

Combined STN and NBM Deep Brain Stimulation for Mild Cognitive Impairment in Parkinson's Disease

Identification of Genomic Predictors of Adverse Events After Cardiac Surgery

A 2-Period Crossover Study of BPN14770 in Adults Males With Fragile X Syndrome

Brain Health Virtual Reality Study

Examining Cognitive Function and Brain Abnormalities in Adults With Sickle Cell Disease

Mind-Body Sexual Well-Being Program for Female GI Cancer Survivors

Haloperidol For Outpatient Symptom Management in Patients Diagnosed With Cannabinoid Hyperemesis Syndrome in the Emergrency Department

Autonomic Modulation in Takotsubo Syndrome

Tricuspid Regurgitation Study

DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation

Alvimopan as a Rescue Treatment of Postoperative Ileus

Improving Everyday Task Performance Through Repeated Practice in Virtual Reality.

The Effect of Renal Impairment on the Pharmacokinetics of Oral Treprostinil

Psychosis TMS Study

Calorie Restriction and Brain Function in Mild Cognitive Impairment

Post-Operative Cognitive Dysfunction in Normal Aging Patients Undergoing Elective Orthopedic Surgery

Free Fatty Acids-Induced Hypertension in Obese Subjects (Aim #2)